The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Bisphosphonate Associated Osteonecrosis of the Jaw
Open accessAbstract
In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving high-dose intravenous BP; however, 5% of the cases were in patients with osteoporosis receiving low-dose bisphosphonate therapy. We present the results of a systematic review of the incidence, risk factors, diagnosis, prevention, and treatment of BP associated ONJ. We conducted a comprehensive literature search for relevant studies on BP associated ONJ in oncology and osteoporosis patients published before February 2008.All selected relevant articles were sorted by area of focus. Data for each area were abstracted by 2 independent reviewers. The results showed that the diagnosis is made clinically. Prospective data evaluating the incidence and etiologic factors are very limited. In oncology patients receiving high-dose intravenous BP, ONJ appears to be dependent on the dose and duration of therapy, with an estimated incidence of 1%–12% at 36 months of exposure. In osteoporosis patients, it is rare, with an estimated incidence < 1 case per 100,000 person-years of exposure. The incidence of ONJ in the general population is not known. Currently, there is insufficient evidence to confirm a causal link between low-dose BP use in the osteoporosis patient population and ONJ. We concluded BP associated ONJ is associated with high-dose BP therapy primarily in the oncology patient population. Prevention and treatment strategies are currently based on expert opinion and focus on maintaining good oral hygiene and conservative surgical intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650
Self-citationMarx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.07.010 · Cited by 1,648
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Woo, S.-B., Hellstein, J. W., & Kalmar, J. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00009 · Cited by 1,252
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8670 · Cited by 1,149
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
(2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.11.003 · Cited by 837
Osteonecrosis of the Jaw and Bisphosphonates
(2005) · New England Journal of Medicine · doi:10.1056/nejm200507073530120 · Cited by 744
Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia
Mavrokokki, T., Cheng, A., Stein, B., & Goss, A. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.10.061 · Cited by 650
Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors
Badros, A., Weikel, D., Salama, A., Goloubeva, O., Schneider, A., Rapoport, A., Fenton, R., Gahres, N., Sausville, E., Ord, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2465 · Cited by 593
Berenson, J. R., Hillner, B. E., Kyle, R. A., Anderson, K., Lipton, A., Yee, G. C., & Biermann, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.037 · Cited by 542
Ruggiero, S. L., Fantasia, J., & Carlson, E. (2006) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2006.06.004 · Cited by 507
Migliorati, C. A., Schubert, M. M., Peterson, D. E., & Seneda, L. M. (2005) · Cancer · doi:10.1002/cncr.21130 · Cited by 489
Bisphosphanates and Oral Cavity Avascular Bone Necrosis
Migliorati, C. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.99.132 · Cited by 480
Managing the care of patients with bisphosphonate-associated osteonecrosis
MIGLIORATI, C. A., CASIGLIA, J., EPSTEIN, J., JACOBSEN, P. L., SIEGEL, M. A., & WOO, S.-B. (2005) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2005.0108 · Cited by 468
Kyle, R. A., Yee, G. C., Somerfield, M. R., Flynn, P. J., Halabi, S., Jagannath, S., Orlowski, R. Z., Roodman, D. G., Twilde, P., & Anderson, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1269 · Cited by 409
Hansen, T., Kunkel, M., Weber, A., & James Kirkpatrick, C. (2006) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2006.00391.x · Cited by 368
Ruggiero, S. L., Gralow, J. R., Marx, R. E., Hoff, A. O., Schubert, M. M., Huryn, J. M., Toth, B., Damato, K., & Valero, V. (2006) · Journal of Oncology Practice · doi:10.1200/jop.2.1.7 · Cited by 355
Santini, D., Vincenzi, B., Dicuonzo, G., Avvisati, G., Massacesi, C., Battistoni, F., Gavasci, M., Rocci, L., Tirindelli, M. C., Altomare, V., et al. (2003) · PubMed · Cited by 350
Dimopoulos, M. A., Kastritis, E., Anagnostopoulos, A., Melakopoulos, I., Gika, D., Moulopoulos, L. A., Bamia, C., Terpos, E., Tsionos, K., & Bamias, A. (2006) · PubMed · Cited by 340
Zervas, K., Verrou, E., Teleioudis, Z., Vahtsevanos, K., Banti, A., Mihou, D., Krikelis, D., & Terpos, E. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06230.x · Cited by 297
Brown, J. P. (2002) · Canadian Medical Association Journal · Cited by 286
Self-citationBisphosphonate Osteochemonecrosis (Bis-Phossy Jaw): Is This Phossy Jaw of the 21st Century?
Hellstein, J. W., & Marek, C. L. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.01.010 · Cited by 270
Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases
Bagan, J. V., Murillo, J., Jimenez, Y., Poveda, R., Milian, M. A., Sanchis, J. M., Silvestre, F. J., & Scully, C. (2005) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2004.00269.x · Cited by 266
Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment
Ficarra, G., Beninati, F., Rubino, I., Vannucchi, A., Longo, G., Tonelli, P., & Pini Prato, G. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00842.x · Cited by 210
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan, A. A., Sándor, G. K. B., Dore, E., Morrison, A. D., Alsahli, M., Amin, F., Peters, E., Hanley, D. A., CHAUDRY, S. R., Dempster, D. W., et al. (2008) · PubMed · Cited by 204
Self-citationBisphosphonates and osteonecrosis of the jaw
Purcell, P. M., & Boyd, I. W. (2005) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06762.x · Cited by 202
Possible Association between Diabetes and Bisphosphonate-Related Jaw Osteonecrosis
Khamaisi, M., Regev, E., Yarom, N., Avni, B., Leitersdorf, E., Raz, I., & Elad, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2036 · Cited by 200
Bagan, J. V., Jimenez, Y., Murillo, J., Hernandez, S., Poveda, R., Sanchis, J. M., Diaz, J. M., & Scully, C. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.08.001 · Cited by 189
Hyperbaric Oxygen Treatment and Bisphosphonate-Induced Osteonecrosis of the Jaw: A Case Series
Freiberger, J. J., Padilla-Burgos, R., Chhoeu, A., Kraft, K. H., Boneta, O., Moon, R. E., & Piantadosi, C. A. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.03.019 · Cited by 175
Osteonecrosis of the Mandible or Maxilla Associated with the use of New Generation Bisphosphonates
Farrugia, M. C., Summerlin, D., Krowiak, E., Huntley, T., Freeman, S., Borrowdale, R., & Tomich, C. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000187398.51857.3c · Cited by 167
Bisphosphonates and avascular necrosis of the jaw: a possible association
Carter, G., Goss, A. N., & Doecke, C. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06761.x · Cited by 156
Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy
Melo, M. D., & Obeid, G. (2005) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2005.0110 · Cited by 151
Starck, W. J., & Epker, B. N. (1995) · PubMed · Cited by 151
Imaging Findings of Bisphosphonate-Associated Osteonecrosis of the Jaws
Phal, P. M., Myall, R. W. T., Assael, L. A., & Weissman, J. L. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0518 · Cited by 149
Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals
Magopoulos, C., Karakinaris, G., Telioudis, Z., Vahtsevanos, K., Dimitrakopoulos, I., Antoniadis, K., & Delaroudis, S. (2007) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2006.08.004 · Cited by 138
Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: A new clinical entity
Lugassy, G., Shaham, R., Nemets, A., Ben‐Dor, D., & Nahlieli, O. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.015 · Cited by 136
Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy
Hoff, A. O., Toth, B. B., Altundağ, K., Guarneri, V., Adamus, A., Nooka, A. K., Sayegh, G., Johnson, M. M., Gagel, R. F., & Hortobágyi, G. N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.8528 · Cited by 133
Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
Melo, M. D., & Obeid, G. (2005) · PubMed · Cited by 132
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients
Bisdas, S., Chambron-Pinho, N., Smolarz, A., Sader, R. A., Vogl, T. J., & Mack, M. G. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.04.023 · Cited by 128
Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases
Dimitrakopoulos, I., Magopoulos, C., & Karakasis, D. (2006) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2006.02.022 · Cited by 119
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients
Wass, J. A. H. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.07.016 · Cited by 114
Osteonecrosis of the jaw associated with pamidronate therapy
Zarychanski, R., Elphee, E., Walton, P., & Johnston, J. B. (2005) · American Journal of Hematology · doi:10.1002/ajh.20481 · Cited by 102
Lenz, J., Steiner-Krammer, B., Schmidt, W., Fietkau, R., Mueller, P. C., & Gundlach, K. K. H. (2005) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2005.07.007 · Cited by 93
Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
Merigo, E., Manfredi, M., Meleti, M., Guidotti, R., Ripasarti, A., Zanzucchi, E., D'Aleo, P., Corradi, D., Corcione, L., Sesenna, E., et al. (2006) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 92
Primary Surgical Therapy for Osteonecrosis of the Jaw Secondary to Bisphosphonate Therapy
Kademani, D., Koka, S., Lacy, M. Q., & Rajkumar, S. V. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.8.1100 · Cited by 91
Zavras, A. I., & Zhu, S. (2006) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.02.011 · Cited by 85
Tooth Extraction Socket Healing in Pediatric Patients Treated with Intravenous Pamidronate
Chahine, C., Cheung, M., Head, T. W., Schwartz, S., Glorieux, F. H., & Rauch, F. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.05.003 · Cited by 83
Self-citationKatz, H. R. (2005) · Journal of Endodontics · doi:10.1097/01.don.0000186481.96169.cd · Cited by 79
Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy
Pires, F. R., Miranda, Á., Cardoso, E., Cardoso, A. S., Fregnani, E. R., Pereira, C. M., Corrêa, M., Almeida, J., Alves, F. D. A., Lopes, M., et al. (2005) · Oral Diseases · doi:10.1111/j.1601-0825.2005.01130.x · Cited by 78
Siniscalchi, E. N., Musolino, C., Allegra, A., Oteri, G., Cicciù, M., Alonci, A., Quartarone, E., Alati, C., & Ponte, F. S. D. (2006) · Acta Haematologica · doi:10.1159/000097876 · Cited by 70
Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
Pastor-Zuazaga, D., Crelgo, J. G., Gorbea, R. M., Pérez, A. E., & Sebastián-López, C. (2006) · PubMed · Cited by 48
Estilo, C. L., Poznak, C. H. V., Williams, T. L., Evtimovska, E., Tkach, L., Halpern, J., Tunick, S., & Huryn, J. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.8088 · Cited by 47
Shimura, K., Shimazaki, C., Taniguchi, K., Akamatsu, S., Okamoto, M., Uchida, R., Nomura, K.-I., Inaba, T., Horiike, S., Kanamura, N., et al. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06110 · Cited by 43
Bisphosphonate-Associated Osteonecrosis of the Jaw
Treister, N. S., & Woo, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmicm055784 · Cited by 37
Jaw Complications Associated with Bisphosphonate Use in Patients with Plasma Cell Dyscrasias
Thakkar, S. G., Isada, C. M., Smith, J. D., Karam, M. A., Reed, J., Tomford, J. W., Englund, K., Richmond, M., Licata, A., Hatch, C. L., et al. (2006) · Medical Oncology · doi:10.1385/mo:23:1:51 · Cited by 33
Diabetes and the Risk of Osteonecrosis of the Jaw
Favus, M. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0098 · Cited by 31
Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve cases.
Salesi, N., Pistilli, R., Marcelli, V., Govoni, F. A., Bozza, F., Bossone, G., Venturelli, V., Cocco, B. D., Pacetti, U., Ciorra, A., et al. (2006) · PubMed · Cited by 30
Thalidomide and immunomodulatory drugs in the treatment of cancer
Bamias, A., & Dimopoulos, M. A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.1.45 · Cited by 30
Pozzi, S., Marcheselli, R., Sacchi, S., Quarta, G., Musto, P., Caparrotti, G., Natale, D., Pianezze, G., Polimeno, G., Pitini, V. V., et al. (2005) · Blood · doi:10.1182/blood.v106.11.5057.5057 · Cited by 26
Shogren, K. L., Turner, R. T., Yaszemski, M. J., & Maran, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060914 · Cited by 19
Cited by
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.04.031 · Cited by 2,905
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,353
Self-citationQaseem, A., Forciea, M. A., McLean, R. M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m15-1361 · Cited by 676
Ström, O., Borgström, F., Kanis, J. A., Compston, J., Cooper, C., McCloskey, E. V., & Jönsson, B. (2011) · Archives of Osteoporosis · doi:10.1007/s11657-011-0060-1 · Cited by 546
Self-citation
Metadata
- Authors
- KHAN, A. A., SÁNDOR, G. K. B., DORE, E., MORRISON, A. D., ALSAHLI, M., AMIN, F., PETERS, E., HANLEY, D. A., CHAUDRY, S. R., LENTLE, B., DEMPSTER, D. W., GLORIEUX, F. H., NEVILLE, A. J., TALWAR, R. M., CLOKIE, C. M., MARDINI, M. A., PAUL, T., KHOSLA, S., JOSSE, R. G., SUTHERLAND, S., LAM, D. K., CARMICHAEL, R. P., BLANAS, N., KENDLER, D., PETAK, S., STE-MARIE, L. G., BROWN, J., EVANS, A. W., RIOS, L., & COMPSTON, J. E.
- Venue
- The Journal of Rheumatology
- Publisher
- The Journal of Rheumatology
- Published
- 2009-03
- Volume
- 36
- Issue
- 3
- Pages
- 478-490
- ISSN
- 0315-162X (ISSN-L)
- 1499-2752
- OpenAlex
- W1994799035
- Cited by
- 280
- References
- 64
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.